- IPC GENERAL
- IPC News
Lone Skov, MD, PhD
Herlev and Gentofte Hospital, University of Copenhagen
Hellerup, Denmark
IPC Board Member
- Professor Lone Skov is a Professor and Senior Physician in the Department of Dermatology and Allergy at Herlev and Gentofte Hospital, University of Copenhagen.
- Her primary clinical and research interests lie in inflammatory skin diseases, mainly psoriasis and atopic dermatitis.
- Professor Skov is a member of various national and international scientific societies, including the European Academy of Dermatology and Venereology (EADV) and the Skin Inflammation & Psoriasis International Network (SPIN). She has served as the past president of the Danish Society of Dermato-Venerology and chair of the Group for Guidelines and Research on Psoriasis of the Danish Society for Dermatology.
- Professor Skov was appointed to the IPC Board of Directors in 2023 and became an IPC Councilor in 2013. She is a member of the IPC Disease Severity Working Group and the IPC Finance Committee and Chair of the IPC Membership Committee.
Professor Lone Skov’s journey into dermatology was fueled by her fascination with immunology. Her academic career began as a PhD student in the lab of Dr. Ole Baadsgaard at the University of Copenhagen, where she explored the impact of ultraviolet light on the immune system. This pivotal experience led her to specialize in dermatology. During this time, clinical trials and the advent of biological therapy for psoriasis were emerging. “Witnessing the transformative effects of these treatments on patients, I was inspired to dedicate my career to improving the lives of people affected by psoriasis,” she said.
Professor Skov has been instrumental in developing and implementing unique Danish registries, playing a vital role in the steering group that initiated one of the first registers for the use of biological treatments in clinical practice, DERMBIO. Her research has focused on psoriasis’s epidemiology, immunology, and clinical aspects. Concurrently, she has strived to optimize treatment protocols at her hospital and across Denmark. She explained, “In optimizing the treatment, I have focused on systemic treatment of psoriasis as well as detecting and preventing comorbidities related to psoriasis.”
"It is my hope that IPC can help make up-to-date treatments for psoriasis available to the entire world."
— Lone Skov, MD, PhD
Professor Jonathan Barker, a past president of IPC, facilitated her introduction to the IPC during her time as a PhD student. “Participating in IPC, primarily through my participation in the working group on biosimilar treatment and later the recategorization of disease severity, has given me insight into the limited treatment options for patients with psoriasis in developing countries,” she noted.
Professor Skov is particularly concerned about the limited treatment options in developing countries. She expresses her commitment to the IPC’s mission with heartfelt clarity: “It is my hope that IPC can help make up-to-date treatments for psoriasis available to the entire world.” She finds great fulfillment in her role on the IPC Board, collaborating with dedicated individuals to improve the lives of psoriasis patients worldwide. “It is a pleasure for me to be on the IPC Board and to work with so many people who are working to improve the lives of patients with psoriasis,” she added.
Professor Lone Skov’s dedication to the field of dermatology and her ongoing efforts to enhance psoriasis treatment underscore her invaluable contribution to the IPC and the global community it serves.
